# Gene Transfer Clinical Trial for Krabbe Disease

> **NCT04693598** · PHASE1,PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **Forge Biologics, Inc** · enrollment: 6 (estimated)

## Conditions studied

- Krabbe Disease

## Interventions

- **BIOLOGICAL:** FBX-101

## Key facts

- **NCT ID:** NCT04693598
- **Lead sponsor:** Forge Biologics, Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2021-11-05
- **Primary completion:** 2026-11
- **Final completion:** 2026-11
- **Target enrollment:** 6 (ESTIMATED)
- **Last updated:** 2025-01-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04693598

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04693598, "Gene Transfer Clinical Trial for Krabbe Disease". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT04693598. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*